6533b7dafe1ef96bd126f470

RESEARCH PRODUCT

Anti-inflammatory dihydroxanthones from a Diaporthe species

Markus RohrUlrich KauhlGerhard ErkelJonathan GroßTill OpatzAnna Maria Kiefer

subject

Chemokinegenetic structuresmedicine.drug_classClinical BiochemistryInflammation01 natural sciencesBiochemistryMarker geneAnti-inflammatory03 medical and health sciencesDiaporthemedicineCXCL10STAT1Molecular Biology030304 developmental biology0303 health sciencesbiology010405 organic chemistryChemistryTransfectionbiology.organism_classificationMolecular biology0104 chemical sciencesbiology.proteinmedicine.symptom

description

Abstract In a search for anti-inflammatory compounds from fungi inhibiting the promoter activity of the small chemokine CXCL10 (Interferon-inducible protein 10, IP-10) as a pro-inflammatory marker gene, the new dihydroxanthone methyl (1R, 2R)-1,2,8-trihydroxy-6-(hydroxymethyl)-9-oxo-2,9-dihydro-1H-xanthene-1-carboxylate (2) and the previously described dihydroxanthone AGI-B4 (1) were isolated from fermentations of a Diaporthe species. The structures of the compounds were elucidated by a combination of one- and two-dimensional NMR spectroscopy, mass spectrometry, and calculations using density functional theory (DFT). Compounds 1 and 2 inhibited the LPS/IFNγ induced CXCL10 promoter activity in transiently transfected human MonoMac6 cells in a dose-dependent manner with IC50 values of 4.1 µM (±0.2 µM) and 1.0 µM (±0.06 µM) respectively. Moreover, compounds 1 and 2 reduced mRNA levels and synthesis of pro-inflammatory mediators such as cytokines and chemokines in LPS/IFNγ stimulated MonoMac6 cells by interfering with the Stat1 and NFκB pathway.

https://doi.org/10.1515/hsz-2021-0192